Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8152
Reference
Drug alert 17/2024
Name
Drug Alert Class 4 Drug Alert 17 2024 – Class 4 medicines defect information caution in use – Fresenius Kabi Ltd – sodium chloride 0.9% intravenous infusion BP (Freeflex and Freeflex Plus)
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Industry
Medicines Recall
Description
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS. Some batches were packaged without the patient information leaflet (PIL), and some were packaged with an older version of the PIL.
Although two of batches that have been packaged without a PIL have not yet been distributed, due to the consideration of supply and that Fresenius Kabi Limited will be providing printed copies of the correct PIL, these batches will not be repackaged and will continue to be distributed.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2024-05-22 09:09:00
Click to go back to homepage